A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure

Controlled Trial ◽

Severe Congestive Heart Failure ◽

Double Blind ◽

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.

Circulation ◽

10.1161/01.cir.79.3.491 ◽

1989 ◽

Vol 79 (3) ◽

pp. 491-502 ◽

Cited By ~ 153

Author(s):

H Drexler ◽

U Banhardt ◽

T Meinertz ◽

H Wollschläger ◽

M Lehmann ◽

...

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Converting Enzyme ◽

Long Term Effects ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

Converting Enzyme Inhibition

Safety and Efficacy of Sertraline for Depression in Patients with CHF (SADHART-CHF): A randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure

American Heart Journal ◽

10.1016/j.ahj.2008.05.003 ◽

2008 ◽

Vol 156 (3) ◽

pp. 437-444 ◽

Cited By ~ 65

Author(s):

Wei Jiang ◽

Christopher O'Connor ◽

Susan G. Silva ◽

Maragatha Kuchibhatla ◽

Michael S. Cuffe ◽

...

Keyword(s):

Heart Failure ◽

Major Depression ◽

Controlled Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Effect of thyroid hormone supplementation on survival of euthyroid dogs with congestive heart failure due to systolic myocardial dysfunction: a double-blind, placebo-controlled trial

Research in Veterinary Science ◽

10.1016/s0034-5288(03)00111-5 ◽

2003 ◽

Vol 75 (3) ◽

pp. 195-201 ◽

Cited By ~ 6

Author(s):

Anna Tidholm ◽

T Falk ◽

S Gundler ◽

H Svensson ◽

B Åblad ◽

...

Keyword(s):

Heart Failure ◽

Thyroid Hormone ◽

Myocardial Dysfunction ◽

Controlled Trial ◽

Double Blind ◽

Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial – Expression of concern

British Journal Of Nutrition ◽

10.1017/s0007114521002063 ◽

2021 ◽

pp. 1-1

Author(s):

Fariba Raygan ◽

Milad Behnejad ◽

Vahidreza Ostadmohammadi ◽

Fereshteh Bahmani ◽

Mohammad A Mansournia ◽

...

Keyword(s):

Heart Failure ◽

Insulin Resistance ◽

Controlled Trial ◽

Selenium Supplementation ◽

Metabolic Risk ◽

Double Blind ◽

Invited commentary in response to: selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial

British Journal Of Nutrition ◽

10.1017/s0007114518001228 ◽

2018 ◽

Vol 120 (1) ◽

pp. 1-2 ◽

Cited By ~ 1

Author(s):

Wen-Hsing Cheng ◽

Gerald F. Combs

Keyword(s):

Heart Failure ◽

Insulin Resistance ◽

Controlled Trial ◽

Selenium Supplementation ◽

Metabolic Risk ◽

Double Blind ◽

The Targeting Acute Congestion with Tolvaptan in Congestive Heart Failure Study: A Randomized, Double blind, Placebo-Controlled Trial in Acute Heart Failure

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2016.09.010 ◽

2016 ◽

Vol 22 (11) ◽

pp. 939

Author(s):

Robert J. Mentz ◽

G. Michael Felker ◽

Robert Cole ◽

Kirkwood F. Adams ◽

Gregory Egnaczyk ◽

...

Keyword(s):

Heart Failure ◽

Acute Heart Failure ◽

Controlled Trial ◽

Double Blind ◽

1031-35 Value of Ibopamine as Adjunct to Maximal Oral Medication in Patients with Moderately Severe Congestive Heart Failure; a Double-Blind, Placebo-controlled Study

Journal of the American College of Cardiology ◽

10.1016/0735-1097(95)93190-n ◽

1995 ◽

Vol 25 (2) ◽

pp. 417A

Author(s):

Balázs M. Szabó ◽

Dirk J. van Veldhuisen ◽

Pieter H. van der Burgh ◽

Joost Kruik ◽

K.I. Lie

Keyword(s):

Heart Failure ◽

Severe Congestive Heart Failure ◽

Oral Medication ◽

Controlled Study ◽

Double Blind ◽

Increased exercise ejection fraction and reversed remodeling after long-term treatment with metoprolol in congestive heart failure: a randomized, stratified, double-blind, placebo-controlled trial in mild to moderate heart failure due to ischemic or idiop

European Journal of Heart Failure ◽

10.1016/s1388-9842(03)00105-3 ◽

2003 ◽

Vol 5 (5) ◽

pp. 679-691 ◽

Cited By ~ 40

Author(s):

F. Waagstein ◽

O. Strömblad ◽

B. Andersson ◽

M. Böhm ◽

M. Darius ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Controlled Trial ◽

Term Treatment ◽

Double Blind ◽

Double Blind Placebo ◽

Moderate Heart Failure ◽

Long Term Treatment

Double-blind, placebo-controlled (P), comparison of enoximone (E) and dobutamine (D) infusions in moderate to severe congestive heart failure patients (NYHA III–IV)

Journal of the American College of Cardiology ◽

10.1016/0735-1097(91)92064-s ◽

1991 ◽

Vol 17 (2) ◽

pp. A274 ◽

Cited By ~ 1

Author(s):

Edward Gilbert

Keyword(s):

Heart Failure ◽

Severe Congestive Heart Failure ◽

Double Blind ◽

Double Blind Placebo ◽

Heart Failure Patients

Central and regional hemodynamic effects of oral enoximone in congestive heart failure: A double-blind, placebo-controlled study

American Heart Journal ◽

10.1016/0002-8703(88)90076-2 ◽

1988 ◽

Vol 115 (5) ◽

pp. 1051-1059 ◽

Cited By ~ 20

Author(s):

Carl V. Leier ◽

John J. Lima ◽

Steffen E.L. Meiler ◽

Donald V. Unverfeth

Keyword(s):

Heart Failure ◽

Controlled Study ◽

Hemodynamic Effects ◽

Double Blind ◽